Morgan Stanley’s CervoMed CRVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Buy |
375,290
+238,233
| +174% | +$1.5M | ﹤0.01% | 4594 |
|
|
2025
Q1 | $1.25M | Buy |
137,057
+86,429
| +171% | +$791K | ﹤0.01% | 4897 |
|
|
2024
Q4 | $118K | Buy |
50,628
+5,525
| +12% | +$12.9K | ﹤0.01% | 5991 |
|
|
2024
Q3 | $659K | Buy |
45,103
+37,436
| +488% | +$547K | ﹤0.01% | 5272 |
|
|
2024
Q2 | $131K | Buy |
7,667
+7,665
| +383,250% | +$131K | ﹤0.01% | 5863 |
|
|
2024
Q1 | $47 | Sell |
2
-2
| -50% | -$47 | ﹤0.01% | 7503 |
|
|
2023
Q4 | $30 | Sell |
4
-360
| -99% | -$2.7K | ﹤0.01% | 7734 |
|
|
2023
Q3 | $1.68K | Sell |
364
-184
| -34% | -$850 | ﹤0.01% | 7157 |
|
|
2023
Q2 | $1.83K | Hold |
548
| – | – | ﹤0.01% | 7210 |
|
|
2023
Q1 | $2.27K | Hold |
548
| – | – | ﹤0.01% | 7219 |
|
|
2022
Q4 | $2.77K | Hold |
548
| – | – | ﹤0.01% | 7293 |
|
|
2022
Q3 | $3K | Hold |
548
| – | – | ﹤0.01% | 7373 |
|
|
2022
Q2 | $4K | Sell |
548
-26,852
| -98% | -$196K | ﹤0.01% | 7442 |
|
|
2022
Q1 | $7K | Sell |
27,400
-8
| -0% | -$2 | ﹤0.01% | 7496 |
|
|
2021
Q4 | $8K | Buy |
27,408
+20,005
| +270% | +$5.84K | ﹤0.01% | 7526 |
|
|
2021
Q3 | $4K | Buy |
7,403
+3
| +0% | +$2 | ﹤0.01% | 7536 |
|
|
2021
Q2 | $5K | Sell |
7,400
-2,600
| -26% | -$1.76K | ﹤0.01% | 7372 |
|
|
2021
Q1 | $9K | Buy |
10,000
+9,000
| +900% | +$8.1K | ﹤0.01% | 6967 |
|
|
2020
Q4 | $1K | Buy |
+1,000
| New | +$1K | ﹤0.01% | 6940 |
|
|
2020
Q2 | – | Sell |
-37
| Closed | – | – | 6617 |
|
|
2020
Q1 | $0 | Hold |
37
| – | – | ﹤0.01% | 6582 |
|
|
2019
Q4 | $0 | Sell |
37
-963
| -96% | – | ﹤0.01% | 6664 |
|
|
2019
Q3 | $2K | Buy |
1,000
+749
| +298% | +$1.5K | ﹤0.01% | 6472 |
|
|
2019
Q2 | $1K | Buy |
+251
| New | +$1K | ﹤0.01% | 6527 |
|
|
2017
Q3 | – | Sell |
-100
| Closed | – | – | 6542 |
|
|
2017
Q2 | $0 | Sell |
100
-12,346
| -99% | – | ﹤0.01% | 6595 |
|
|
2017
Q1 | $50K | Buy |
+12,446
| New | +$50K | ﹤0.01% | 5826 |
|